Fluoroestradiol (18F)

DIAGNOSTIC_TEST4 trials

Sponsors

Assistance Publique - Hôpitaux de Paris, Zhimin Shao, Asan Medical Center

Conditions

Breast Cancer InvasiveMetastatic Breast CancerStage III Breast Cancer

Phase 2

Diagnostic Performance of [18F]FES PET/CT for Axillary LN Metastasis in ER-positive Breast Cancer

CompletedNCT06695039

Asan Medical CenterBreast Cancer Invasive

Start: 2024-11-18End: 2025-10-02Updated: 2025-12-02

[18F]FES PET/CT for the Detection of Distant Metastasis in Low-grade ER-positive Stage III Breast Cancer

RecruitingNCT07314073

Asan Medical CenterStage III Breast Cancer

Start: 2025-12-24End: 2029-12-31Target: 85Updated: 2026-01-02

Unknown Phase

Fluoroestradiol PET Imaging in Predicting Response to Hormone Therapy of Breast Cancer

CompletedNCT01627704

Assistance Publique - Hôpitaux de ParisMetastatic Breast Cancer

Start: 2012-06-30End: 2015-01-31Updated: 2015-10-14

Study to Determine the Utility of FES-PET in the Prediction of Response to Fulvestrant in Women With Estrogen Positive Metastatic Breast Cancer

CompletedNCT03507088

Zhimin ShaoMetastatic Breast Cancer

Start: 2015-09-01End: 2018-07-01Updated: 2019-05-08